Simmons deemed her to be “a healthy 59-year-old female who has a medical history notable for seasonal allergies and urticaria ...

Remibrutinib, an oral Bruton’s tyrosine kinase inhibitor, reduced itch and hives in patients with chronic spontaneous urticaria and showed a favorable safety profile at week 12 in two trials.

There will be numerous sessions, including a special one on Monday morning, Forum 83, titled “Chronic Urticaria: What’s New,” which will provide the latest updates on CSU diagnosis and ...